Trials / Completed
CompletedNCT03884309
Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula
Tolerance, Compliance and Growth of Infants Fed an Extensively Hydrolyzed Infant Formula With Added Human Milk Oligosaccharides
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Abbott Nutrition · Industry
- Sex
- All
- Age
- 60 Days
- Healthy volunteers
- Not accepted
Summary
This is a single group, non-randomized, multicenter study to assess the effects of a hypoallergenic casein hydrolysate powdered infant formula on gastrointestinal (GI) tolerance, growth and compliance in an intended use infant population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Experimental Hydrolyzed Protein Infant Formula | fed ad libitum |
Timeline
- Start date
- 2019-03-25
- Primary completion
- 2020-01-07
- Completion
- 2020-01-07
- First posted
- 2019-03-21
- Last updated
- 2020-02-05
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03884309. Inclusion in this directory is not an endorsement.